Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
Autor: | Morgan A. Marks, Matthew Pilsbury, Wail A. Hayajneh, Cerise K. James, Erik J. Dasbach, Camilo J. Acosta, Vincent J. Daniels, Muhammet Nabi Kanıbir, Elamin H. Elbasha, Michelle G. Goveia |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
Economics Cost effectiveness Hepatitis A vaccine Hepatitis a lcsh:Infectious and parasitic diseases 03 medical and health sciences 0302 clinical medicine Environmental health Medicine lcsh:RC109-216 030212 general & internal medicine Health technology assessment Jordan business.industry Public health Incidence (epidemiology) Cost-effectiveness analysis Hepatitis A medicine.disease Vaccination Infectious Diseases Impact Economic evaluation 030211 gastroenterology & hepatology Immunization business Simulation Research Article |
Zdroj: | BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-12 (2018) BMC Infectious Diseases |
ISSN: | 1471-2334 |
DOI: | 10.1186/s12879-018-3034-8 |
Popis: | Background As the socioeconomic conditions in Jordan have improved over recent decades the disease and economic burden of Hepatitis A has increased. The purpose of this study is to assess the potential health and economic impact of a two-dose hepatitis A vaccine program covering one-year old children in Jordan. Methods We adapted an age-structured population model of hepatitis A transmission dynamics to project the epidemiologic and economic impact of vaccinating one-year old children for 50 years in Jordan. The epidemiologic model was calibrated using local data on hepatitis A in Jordan. These data included seroprevalence and incidence data from the Jordan Ministry of Health as well as hospitalization data from King Abdullah University Hospital in Irbid, Jordan. We assumed 90% of all children would be vaccinated with the two-dose regimen by two years of age. The economic evaluation adopted a societal perspective and measured benefits using the quality-adjusted life-year (QALY). Results The modeled vaccination program reduced the incidence of hepatitis A in Jordan by 99%, 50 years after its introduction. The model projected 4.26 million avoided hepatitis A infections, 1.42 million outpatient visits, 22,475 hospitalizations, 508 fulminant cases, 95 liver transplants, and 76 deaths over a 50 year time horizon. In addition, we found, over a 50 year time horizon, the vaccination program would gain 37,502 QALYs and save over $42.6 million in total costs. The vaccination program became cost-saving within 6 years of its introduction and was highly cost-effective during the first 5 years. Conclusion A vaccination program covering one-year old children is projected to be a cost-saving intervention that will significantly reduce the public health and economic burden of hepatitis A in Jordan. Electronic supplementary material The online version of this article (10.1186/s12879-018-3034-8) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |